Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Photo ID requirements could create 'faff' at borders, says Steam Packet boss
DHSC minister 'absolutely committed' to reopening Ramsey hospital
Enterprise minister 'optimistic' following challenging period for tourism sector
Plans to protect Douglas Head to be laid before Tynwald in May